Black men benefit more from screening
Black men benefit more from prostate cancer screening in general and from personalized biomarkers because they are more likely to
harbor genomically-aggressive cancer, even if it appears they have low-risk disease.
Prostate cancer mortality rates in Black men are approximately 2 to 4 times higher than those in every other racial and ethnic group.
Siegel RL, et al, CA Cancer J Clin 2023, 73:17-48.